Related Experiment Videos
Cyclin D1 genotype and expression in sporadic hemangioblastomas
Johanna M M Gijtenbeek1, Sandra H E Boots-Sprenger, Barbara Franke
1Department of Neurology, Radboud University, Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. j.gijtenbeek@neuro.umcn.nl
Journal of Neuro-Oncology
|September 28, 2005
Summary
The CCND1 gene genotype does not appear to influence the development of sporadic central nervous system (CNS) hemangioblastomas. Cyclin D1 expression varies in these tumors, but its genetic basis is not linked to CCND1 genotype.
Area of Science:
- Neuro-oncology
- Cancer genetics
- Molecular biology
Background:
- Central nervous system (CNS) hemangioblastomas are vascular tumors associated with von Hippel-Lindau (VHL) disease or occurring sporadically.
- The CCND1 gene, encoding cyclin D1, is crucial for cell cycle control and often overexpressed in cancers.
- A common CCND1 polymorphism (870G > A) affects gene splicing and has been linked to cancer outcomes and VHL disease susceptibility.
Purpose of the Study:
- To investigate the role of CCND1 gene polymorphism in sporadic CNS hemangioblastomas.
- To analyze the association between CCND1 genotype and cyclin D1 expression in CNS hemangioblastomas.
Main Methods:
- Genotyping of the CCND1 870G > A polymorphism in tumor tissues from 17 sporadic and 5 VHL-related CNS hemangioblastomas.
- Immunohistochemical analysis to assess the extent and localization of cyclin D1 expression in these tumors.
Main Results:
- No significant deviation in CCND1 genotype distribution or allele frequencies was observed in sporadic hemangioblastomas compared to expected values.
- No correlation was found between CCND1 genotype and age at onset.
- Cyclin D1 expression was highly variable within and between tumors, with no clear link to CCND1 genotype.
Conclusions:
- CCND1 genotype is unlikely to be a significant genetic modifier in the oncogenesis of sporadic CNS hemangioblastomas.
- Variable cyclin D1 expression is a characteristic of sporadic hemangioblastomas, irrespective of CCND1 genotype.